Search

everythinglearnresearchcommunity

for

Search:↓

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Older skin has higher cancer risk due to inflammation and stem cell issues.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

JAK inhibitors help treat alopecia areata but have high recurrence after stopping.

A mix of Panax ginseng and bee-pollen may help prevent prostate enlargement in rats.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Cancer treatments often cause skin, nail, and hair problems.

The effects of estrogen on human scalp hair growth are unclear and need more research.

Gray hair can potentially be reversed, leading to new treatments.